1. Home
  2. SFBS vs IRON Comparison

SFBS vs IRON Comparison

Compare SFBS & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ServisFirst Bancshares Inc.

SFBS

ServisFirst Bancshares Inc.

HOLD

Current Price

$73.32

Market Cap

4.0B

Sector

Finance

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$90.62

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFBS
IRON
Founded
2005
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.4B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SFBS
IRON
Price
$73.32
$90.62
Analyst Decision
Hold
Strong Buy
Analyst Count
1
13
Target Price
$80.00
$108.85
AVG Volume (30 Days)
269.7K
573.4K
Earning Date
01-26-2026
11-06-2025
Dividend Yield
2.05%
N/A
EPS Growth
24.86
N/A
EPS
4.67
N/A
Revenue
$497,701,000.00
N/A
Revenue This Year
$24.89
N/A
Revenue Next Year
$16.87
N/A
P/E Ratio
$15.63
N/A
Revenue Growth
16.24
N/A
52 Week Low
$66.48
$30.82
52 Week High
$93.90
$99.50

Technical Indicators

Market Signals
Indicator
SFBS
IRON
Relative Strength Index (RSI) 51.55 50.55
Support Level $73.72 $86.75
Resistance Level $76.21 $94.51
Average True Range (ATR) 2.05 3.83
MACD 0.27 -0.85
Stochastic Oscillator 42.23 27.22

Price Performance

Historical Comparison
SFBS
IRON

About SFBS ServisFirst Bancshares Inc.

Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: